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 1.0 INTRODUCTION 
1.1 Diabetes mellitus (DM) 
Diabetes is a serious complex condition which can affect the entire body. 
Diabetes requires daily self care and if complications develop, diabetes can have a 
significant impact on quality of life and can reduce life expectancy. While there is 
currently no cure for diabetes, you can live an enjoyable life by learning about the 
condition and effectively managing it. It is a fast-growing global problem with huge 
social, health and economic consequences. It is estimated that in 2010 there were 
globally 285 million people (approximately 6.4% of the adult population) suffering 
from this disease. This number is estimated to increase to 430 million in the absence 
of better control or cure. An ageing population and obesity are two main reasons for 
the increase. Furthermore it has been shown that almost 50% of the putative 
diabetics are not diagnosed until 10 years after onset of the disease, hence the real 
prevalence of global diabetes must be astronomically high1.  
This high blood sugar produces the symptoms of frequent 
urination, increased thirst, and increased hunger. Untreated, diabetes can cause many 
complications. Acute complications include diabetic ketoacidosis and non ketotic 
hyperosmolarcoma. Serious long-term complications include heart disease, stroke, 
kidney failure, foot ulcers and damage to the eyes2-7.  
Indian physicians around the same time identified the disease and classified 
it as Madhumeha or "honey urine", noting but the urine would attract ants. This is 
possibly due to the diet and life-style of the ancient people, or because the clinical 
symptoms were observed during the advanced stage of the disease. Galen named the 
disease "Diarrhea of the urine" (diarrhea urinosa). The earliest surviving work with a 
detailed reference to diabetes is that of Aretaeus of Cappadocia (2nd or early 3rd 
century CE). Type 1 and type 2 diabetes were identified as separate conditions for 
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the first time by the Indian physicians Sushruta and Charaka in 400-500 CE with 
type 1 associated with youth and type 2 with being overweight. Effective treatment 
was not developed until the early part of the 20th century, when 
Canadians Frederick Banting and Charles Herbert Best isolated and purified insulin 
in 1921 and 1922.  This was followed by the development of the long-acting insulin 
NPH in the 1940s.  
1.2 Main Symptoms of Type II Diabetes 
Indian physicians around the same time identified the disease and classified 
it as Madhumeha or "honey urine", noting but the urine would attract ants. 
Figure No:1- Main Symptoms of Diabetes 
 
1.3 Overview of the Most Significant Symptoms of Diabetes 
The classic symptoms of untreated diabetes are weight loss, polyuria 
(frequent urination), polydipsia (increased thirst), and polyphagia (increased 
hunger). Symptoms may develop rapidly (weeks or months) in type 1 diabetes, 
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while they usually develop much more slowly and may be subtle or absent in type 2 
diabetes. 
Several other signs and symptoms can mark the onset of diabetes, although 
they are not specific to the disease. In addition to the known ones above, they 
include blurry vision, headache, fatigue, slow healing of cuts, and itchy skin. 
Prolonged high blood glucose can cause glucose absorption in the lens of the eye, 
which leads to changes in its shape, resulting in vision changes. A number of skin 
rashes that can occur in diabetes are collectively known as diabetic dermadromes. 
People (usually with type 1 diabetes) may also experience episodes 
of diabetic Ketoacidosis, a type of metabolic problems characterized by Nausea, 
Vomiting and abdominal pain, the smell of acetone on the breath, deep breathing 
known as Kussmaul breathing, and in severe cases a decreased level of 
consciousness8-17.  
A rare but equally severe possibility is hyperosmolar nonketotic state, which 
is more common in type 2 diabetes and is mainly the result of dehydration. 
1.4 Complications 
All forms of diabetes increase the risk of long-term complications. These 
typically develop after many years (10–20), but may be the first symptom in those 
who have otherwise not received a diagnosis before that time. The major long-term 
complications relate to damage to blood vessels. Diabetes doubles the risk 
of cardiovascular disease and about 75% of deaths in diabetics are due to coronary 
artery disease. Other "macrovascular" diseases are stroke, and peripheral vascular 
disease. 
The primary microvascular complications of diabetes include damage to the 
eyes, kidneys, and nerves. Damage to the eyes, known as diabetic retinopathy, is 
caused by damage to the blood vessels in the retina of the eye, and can result in 
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gradual vision loss and potentially blindness. Damage to the kidneys, known as 
diabetic nephropathy, can lead to tissue scarring, urine protein loss, and 
eventually chronic kidney disease, sometimes requiring dialysis or kidney 
transplant. Damage to the nerves of the body, known as diabetic neuropathy, is the 
most common complication of diabetes. The symptoms can include numbness, 
tingling, pain, and altered pain sensation, which can lead to damage to the 
skin. Diabetes-related foot problems (such as diabetic foot ulcers) may occur, and 
can be difficult to treat, occasionally requiring amputation. Additionally, proximal 
diabetic neuropathy causes painful muscle wasting and weakness18-25. 
There is a link between cognitive deficit and diabetes. Compared to those 
without diabetes, those with the disease have a 1.2 to 1.5-fold greater rate of decline 
in cognitive function. 
1.5 Diagnosis 
Diabetes mellitus is characterized by recurrent or persistent hyperglycemia, and 
is diagnosed by demonstrating any one of the following:  
 Fasting plasma glucose level ≥ 7.0 mmol/l (126 mg/dl) 
 Plasma glucose ≥ 11.1 mmol/l (200 mg/dl) two hours after a 75 g oral 
glucose load as in a glucose tolerance test 
 Symptoms of hyperglycemia and casual plasma glucose ≥ 11.1 mmol/l 
(200 mg/dl) 
 Glycated hemoglobin (Hb A1C) ≥ 6.5%. 
A positive result, in the absence of unequivocal hyperglycemia, should be 
confirmed by a repeat of any of the above methods on a different day. It is 
preferable to measure a fasting glucose level because of the ease of measurement 
and the considerable time commitment of formal glucose tolerance testing, which 
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takes two hours to complete and offers no prognostic advantage over the fasting test. 
According to the current definition, two fasting glucose measurements above 
126 mg/dl (7.0 mmol/l) is considered diagnostic for diabetes mellitus. 
Per the World Health Organization people with fasting glucose levels from 6.1 
to 6.9 mmol/l (110 to 125 mg/dl) are considered to have impaired fasting glucose. 
People with plasma glucose at or above 7.8 mmol/l (140 mg/dl), but not over 
11.1 mmol/l (200 mg/dl), two hours after a 75 g oral glucose load are considered to 
have impaired glucose tolerance. Of these two prediabetic states, the latter in 
particular is a major risk factor for progression to full-blown diabetes mellitus, as 
well as cardiovascular disease. The American Diabetes Association since 2003 uses 
a slightly different range for impaired fasting glucose of 5.6 to 6.9 mmol/l (100 to 
125 mg/dl).  
Glycated hemoglobin is better than fasting glucose for determining risks of 
cardiovascular disease and death from any cause.  
The rare disease diabetes insipidus has similar symptoms to diabetes mellitus, 
but without disturbances in the sugar metabolism (insipidus means "without taste" in 
Latin) and does not involve the same disease mechanisms25-27. 
Table No: 1 Diagnostic Criteria for Diabetes Mellitus 
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1.6 Avoidance and management 
There is no known preventive measure for type 1 diabetes. Type 2 diabetes 
can often be prevented by a person being a normal body weight, physical exercise, 
and following a healthy diet. Dietary changes known to be effective in helping to 
prevent diabetes include a diet rich in whole grains and fiber, and choosing good 
fats, such as polyunsaturated fats found in nuts, vegetable oils, and fish. Limiting 
sugary beverages and eating less red meat and other sources of saturated fatcan also 
help in the prevention of diabetes.  Active smoking is also associated with an 
increased risk of diabetes, so smoking cessation can be an important preventive 
measure as well.  
Diabetes mellitus is a chronic disease, for which there is no known cure 
except in very specific situations. Management concentrates on keeping blood sugar 
levels as close to normal ("euglycemia") as possible, without causing hypoglycemia. 
This can usually be accomplished with diet, exercise, and use of appropriate 
medications (insulin in the case of type 1 diabetes; oral medications, as well as 
possibly insulin, in type 2 diabetes). 
Learning about the disease and actively participating in the treatment is vital 
for people with diabetes, since the complications of diabetes are far less common 
and less severe in people who have well-managed blood sugar levels. The goal of 
treatment is an HbA1C level of 6.5%, but should not be lower than that, and may be 
set higher.  Attention is also paid to other health problems that may accelerate the 
deleterious effects of diabetes. These include smoking, elevated 
cholesterollevels, obesity, high blood pressure, and lack of regular exercise. 
Specialised footwear is widely used to reduce the risk of ulceration, or re-ulceration, 
in at-risk diabetic feet. 
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1.6.1 Lifestyle: 
People with diabetes can benefit from education about the disease and 
treatment, good nutrition to achieve a normal body weight, and sensible exercise, 
with the goal of keeping both short-term and long-term blood glucose levels within 
acceptable bounds. In addition, given the associated higher risks of cardiovascular 
disease, lifestyle modifications are recommended to control blood pressure.  
1.6.2 Treatment options: 
Metformin is generally recommended as a first line treatment for type 2 
diabetes, as there is good evidence that it decreases mortality. Routine use of aspirin, 
however, has not been found to improve outcomes in uncomplicated diabetes. 
Angiotensin converting enzyme inhibitors (ACEIs) improve outcomes in those with 
DM while the similar medications angiotensin receptor blockers (ARBs) do not.  
Type 1 diabetes is typically treated with combinations of regular and 
NPH insulin, or synthetic insulin analogs. When insulin is used in type 2 diabetes, a 
long-acting formulation is usually added initially, while continuing oral medications.  
Doses of insulin are then increased to effect.  
In those with diabetes some recommend blood pressure levels below 
120/80 mmHg; however, evidence only supports less than or equal to somewhere 
between 140/90 mmHg to 160/100 mmHg.  
1.6.3 Surgical transplantation: 
A pancreas transplant is occasionally considered for people with type 1 
diabetes who have severe complications of their disease, including disease 
requiring kidney transplantation. 
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1.6.4 Therapy: 
In countries using a general practitioner system, such as the United 
Kingdom, care may take place mainly outside hospitals, with hospital-based 
specialist care used only in case of complications, difficult blood sugar control, or 
research projects. In other circumstances, general practitioners and specialists share 
care in a team approach. Home telehealth support can be an effective management 
technique. 
1.6.5 Exercise Regimen 
Making healthy food choices is very important to help keep your blood 
glucose level under control. People with diabetes don't need to buy or prepare 
special foods. The foods that are best for someone with diabetes are excellent 
choices for everyone: foods that are low in fat, salt, and sugar, and high in fiber, 
such as beans, fruits, vegetables, and whole grains. These foods help you reach and 
stay at a weight that's good for your body. Regular physical activity is important for 
people with diabetes. Being physically active has been shown to improve blood 
glucose levels in older people whose levels are high. Exercise is especially good for 
people with diabetes because it helps control weight, helps insulin work better to 
lower blood glucose, is good for your heart and lungs, gives you more energy,  
Regular physical activity improves insulin resistance and lipid profile (reduction in 
triglyceride and increase in high-density lipoprotein (HDL)) and lowers blood 
pressure (although blood pressure will rise during exercise),the metabolic benefits in 
type 2 diabetes are lost within 3-10 days of stopping regular exercise, physical 
activity also protects against the development of type 2 diabetes. 
1.6.6 HbA1C Test 
The A1C test is used to detect type 2 diabetes and prediabetes but is not 
recommended for diagnosis of type 1 diabetes or gestational diabetes. The A1C test 
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is a blood test that reflects the average of a person’s blood glucose levels over the 
past 3 months and does not show daily fluctuations. The A1C test is more 
convenient for patients than the traditional glucose tests because it does not require 
fasting and can be performed at any time of the day.The A1C test result are reported 
as a percentage. The higher the percentage, the higher a person’s blood glucose 
levels have been. A normal A1C level is below 5.7 percent. An A1C of 5.7 to 6.4 
percent indicates prediabetes. People diagnosed with prediabetes may be retested in 
1 year. People with an A1C below 5.7 percent may still be at risk for diabetes, 
depending on the presence of other characteristics that put them at risk, also known 
as risk factors. People with an A1C above 6.0 percent should be considered at very 
high risk of developing diabetes. A level of 6.5 percent or above means a person has 
diabetes. 
1.6.7 Plant Drugs 
Allopathic medicines are very costly. In contrast, herbal medicines are very 
cheap. This cost effectiveness makes them all the more alluring. Herbal medicines 
can be brought without prescription and they are available in all most all health 
stores. Some herbs can even be grown at home. For certain ailments, herbal 
medicines are considered to be more effective than allopathic medicines. 
Herbal medicines do not have any side effects, as they are free from 
chemicals. They are also milder than allopathic medicines. The natural detoxification 
process of the body is effectively enhanced by herbal medicines. They can be used to 
cleanse the colon, improve digestion and food absorption. Herbal medicines are also 
very good in boosting the immune system. 
Herbal medicines are very effective in curing various digestive disorders like 
colitis, indigestion, peptic ulcers, and irregular bowel movements.                                                                                                                             
These types of medicines are best for people who are allergic to various types of 
drugs. Herbal medicines are also effective in boosting the mental health. Most of the 
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ailments related to blood circulation like high blood pressure, varicose ulcers, and 
many others can be controlled through herbal medicine. Some herbal medicines are 
very good in reducing the cholesterol level in the blood stream. They are also used to 
treat coronary artery diseases. Herbal medicine can be used to reduce weight by 
regulating appetite. 
1.6.8 Anti-diabetic drugs  
Treating diabetes mellitus by lowering glucose levels in the blood. 
 Traditional Medicines derived from medicinal plants are used by about 60% of the 
world’s population. This review focuses on Indian Herbal drugs and plants used in 
the treatment of diabetes, especially in India. Diabetes is an important human 
ailment afflicting many from various walks of life in different countries. In India it 
is proving to be a major health problem, especially in the urban areas. Though there 
are various approaches to reduce the ill effects of diabetes and its secondary 
complications, herbal formulations are preferred due to lesser side effects, low cost 
and because of their natural origin.                                               
Though different types of oral hypoglycemic agents are available along with 
insulin for the treatment of diabetes, there is increased demand by patients to use the 
natural products with anti diabetic activity. It is a considerable discharge of urine, 
for the most part excessive, of a violet smell and sweet taste and attended with great 
thirst and general debility.  
In this disease, the animal salts are deficient in the urine, while sugar is 
secreted in considerable quantity, and these means are calculated to yield the former, 
and to counteract the later, at the same time that they are capable of correcting the 
morbid action of the digestive organs. 
Diabetes mellitus is one of the common metabolic disorders characterized by 
hyperglycemia due to absolute or relative deficiency of insulin and results in 
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significant morbidity and mortality. Diabetes, by itself, increases the production of 
tissue damaging oxidative stress. Therefore, in diabetes the oxidative stress is 
referred as a case of double jeopardy for any beta cells that survive the disease. 
1.6.9 Diabetes or Madhumeha  
As per Ayurveda is a disease in which there is improper functioning of 
insulin and as a result sugar level in the blood increase. Diabetes may cause heart 
problem, kidney failure, blurred vision if not treated timely28,29. 
Diabetes mellitus is increasing alarmingly worldwide and is defined as the 
abnormal glucose tolerance which affects pancreatic beta cells functions and 
sensitivity leading to progression of diabetes and its related complications. It is a 
chronic disorder of carbohydrate, fat and protein metabolism characterized by 
increased fasting and post prandial blood sugar level and an increased risk of 
vascular complications. It is the most common endocrine disorder in men and 
women, and the major public health problem of epidemic proportions, once believed 
to be a diseased of the west, is becoming an endemic to modernizing and urbanizing 
population in our country. Ayurvedic literature reveals that since the time of Charak 
and Sushrut many herbal medicines in different oral formulations have been 
recommended in Madhumeha (diabetes mellitus) and confident claims of cure are on 
record. 
1.6.10 Types of Diabetes 
 Diabetes mellitus type 1 is a disease caused by the lack of insulin. Insulin 
must be used in Type I, which must be injected or inhaled. 
Diabetes mellitus type 2 is a disease of insulin resistance by cells. 
Treatments include (1) agents which increase the amount of insulin secreted by the 
pancreas, (2) agents which increase the sensitivity of target organs to insulin and (3) 
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agents which decrease the rate at which glucose is absorbed from the gastrointestinal 
tract. 
Patients suffering from this are therefore totally dependent on exogenous 
source of insulin while patients suffering from Type II diabetes (insulin 
independent) are unable to respond to insulin and can be treated with dietary 
changes, exercise and medication. Type II diabetes is the more common form of 
diabetes constituting 90% of the diabetic population30. 
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2.0 LITERATURE REVIEW 
Patil SB, et al (2013)31., studied the antidiabetic activity on ethanolic 
extracts of fruits of Terminalia chebula Retz. (EETC) Alloxan induced diabetic rats. 
EETC showed the nil toxicity upto 500mg/kg BW. The effect of EETC 200mg/kg 
BW was compared with Glibenclamide (600mg/kg BW). The histopathological 
changes caused after induction of alloxan showed the granular cytoplasma, dilation, 
shrunken nuclei and inflammation which were reduced after treatment of the EETC 
200mg/kg BW. The present study on EETC has been confirmed that having the 
pharmacological action against the diabetic condition. It revealed the biological and 
pharmacological properties of Terminalia chebula Retz. (Haritaki). Terminalia 
chebula possesses antibacterial, antifungal, antiviral, antidiabetic, antimutagenic, 
anti-oxidant, antiulcer and wound healting properties. It also prevents cardiac 
damage and it is used for the treatment of kidney diseases. It is a mild safe and 
effective laxative in traditional medicine. Terminalia chebula and its 
phytoconstituents have therapeutic effects with no toxicity.  
Gad MZ, et al (2006)32., evaluated phytoconstituents, bioefficacy and 
phytopharmacological activities of Terminalia chebula. This research shows various 
experimental studies conducted on bioactive compounds isolated from Terminalia 
chebula has prospective use in alleviating aging, cancer, various GIT disorders. 
Swapnil B, et al (2013)33., reviewed Pulsatilla nuttalliana is a multipurpose 
medicinal plant. This review describes the prominence of Pulsatilla nuttalliana in 
therapeutics such as use of crude extract of plants for the amelioration of various 
diseases, morphology, and growth constrains, biochemical composition, biological 
activity in the field of plant tissue culture, natural products and nano-biotechnology. 
Dzhafarova RE, , et al (2009)34., revealed the anti-diabetic properties of 
Pulsatilla nuttalliana stem extracts on Streptozotocin induced diabetic rats. The oral 
administration of various extracts (Hexane, Ethyl acetate and Methanol) of 
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Pulsatilla nuttalliana were found to have potent anti-diabetic activity that reduces 
blood sugar level in Streptozotocin induced diabetic rats. 
Radhika S, et al (2011)35., studied the antidiabetic activity of Pulsatilla 
nuttalliana (Willd.) in Streptozotocin diabetic rats. The probable mechanism by 
which Pulsatilla nuttalliana may act as anti-hypoglycemic drugs is not through 
insulin secretion like sulfonyl ureas. It may be through some peripheral mechanisms, 
such as increasing the glycogen storage in the liver or decreasing the glucose release 
from the liver. 
IshtiaqA, et al (2011)36., reviewed natural medicine from plant source used 
for therapy of diabetes mellitus. This review has been presented in a very interactive 
manner showing geographical region for availability, part of plant used, mechanism 
of action and phytoconstituents responsible for particular action, it will be of great 
importance who interested readers to easily identified and go for further 
research.Presented a review on medicinal plants with antidiabetic activity. The 
effects of this plant may delay the development diabetic complication and correct 
the metabolic abnormalities. This review work stimulates the researchers for further 
research on the potential use of medicinal plants having anti-diabetic potential. 
Kuroda M, et al (2005)37., revealed the Pharmacognostic study of the leaves 
of Syzygium cumini Linn. The present investigation, the detailed pharmacognostic 
study of Syzygium cumini leaf is carried out to lay down the standards which could 
be useful in future experimental studies. evaluated the anti-diabetic, Phytochemical 
in Syzygium cumini (L). Skeels. (Myrtaceae). From the NMR data 4 different 
compounds Lupeol, 12 oleanen-3-ol-3β acetate, Stigmasterol, β-sitosterol were 
identified from n-hexane fraction of plant extract. These compounds have potential 
anti-diabetic activities which support the traditional use of the leaves as being 
remedy for treating diabetes. screened anti-diabetic activity of Syzygium cumini and 
its isolated compounds against streptozotocin induced diabetic rats. A compound 
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mycaminose was isolated from Syzygium cumini extract. The isolated compound 
15mg/kg and ethyl acetate and methanol extracted compounds of Syzygium cumini 
leaves 200 and 400mg/kg was undertaken to evaluate the antidiabetic activity 
against streptozotocin induced diabetic rats. 
Mondal SN, et al (2015)38., provided an overview on Cyperus rotundus. This 
study explore one of the cheapest and effective medicinal resources from this 
automatically growing plant all over india for the using thousands of arthritic 
conditions patients where more than 2% world population suffers from one kind or 
the other kinds of arthritis. tudied the morphological, microscopical and 
physiochemical investigation on the rhizomes of Cyperus rotundus Linn. The study 
includes Pharmacognostical evaluation by macroscopy, microscopy, powder 
analysis, fluorescence characteristic, WHO recommended physiochemical and 
Phytochemical procedures. evaluated the standardization parameters and invitro 
antidiabetic activity of Emblica officinalis fruits as per WHO guidelines. The TLC 
fingerprinting and fluorescence analysis of powdered fruits has been conducted and 
reported. The anti-diabetic activity is conducted by enzyme inhibition (α-
glycosidase) in invitro methods on ethanolic extracts showed significant inhibition. 
Grover JK, et al (2002)39., studies in-vivo anti-diabetic activity of the 
methanolic and aqueous bark extract of the plant Emblica officinalis Gaertn. Results 
depicted that the maximum falloff blood glucose level of normal rats observed after 
6 hrs during fasting blood glucose studies, with the dose of 250mg/kg identified as 
the most effective dose. The effect of bark extracts on serum lipid profile 
(cholesterol, triglycerides, HDL and LDL) were measured in diabetic rats. These 
evidence clearly indicates that the aqueous and methanolic extracs of Emblica 
officinalis stem barks have significant hypo-glycemic potential as well as anti-
diabetic activity. 
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Rajnish Gupta, et al (2011)40., studied the glycemic effects of freeze dried 
Murraya koenigii. The finding of glycemic and Phytochemical studies suggest that 
the identified phytochemicals mightbe responsible for its glycemic effects and hence 
the freeze dried powder may be prescribed as adjunct to diatery therapy and drug 
treatment for managing diabetes mellitus. Studied the effect of extracts of Murraya 
koenigii leaves on the levels of blood glucose and plasma insulin in alloxan induced 
diabetic rats. Murraya koenigii Spreng showed significant reduction. 
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3.0. PLANT PROFILE 
  
Figure No 2. Plant of Pulsatilla nuttalliana -I 
 
Figure No 3. Plant of Pulsatilla nuttalliana-II 
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3.1 Plant Description and Characteristics 
  Kingdom : Plantea 
  Clade  :  Angiosperms 
  Family : Ranunculaceae 
  Genus  : Pulsatilla 
  Species : Pulsatilla nuttalliana 
The Pulsatilla approaches more nearly to its botanical characters. It 
flourishes especially in the dry and sandy bluffs which form the bed of the 
Mississippi. The flower is pale purplish. “The odour of the dried plant is rather faint, 
being slightly camphoraceous, the taste of the dried flowers simply sweetish and 
herbaceous, that of the leaves more astringent with very slight acrimony. The taste 
and to some extent the odour of the fresh plant are both acrid and irritating” (Hale). 
A. W. Miller, a pharmaceutist (referred to by Hale), analyzed P. nutt. The extracted 
substances had an acrid, almost caustic taste, and well-marked camphoraceous 
odour. When volatilized they produced an irritating, pungent vapour, affecting the 
eyes and causing sneezing.  
3.1.1 Phytochemical Constituents 
The analysis revealed the following constituents:  
(1) Organic Grape-sugar, Gum, Resin, an Alkaloid and Anemonic acid, 
Quercetin, Kaempferol. 
(2) Inorganic Sulphate of Potash, Carbonate of potash, Chlorate of 
Potassium, Carbonate of Lime, Magnesia, and “A Proto-Salt of Iron.”  
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3.1.2 Scientifically Proved Activities 
Dr.W. H. Miller (brother of A.W. M.), an allopathists, claimed to have used 
*P. nutt. With success in many chronic eye affections, particularly catarrh, 
amaurosis, and corneal opacities, cutaneous eruptions, and secondary syphilis. Hale 
instituted the first homoeopathic research, and Burt was the first prover. The 
symptoms have a strong resemblance to those of P. nig., and cases cured with P. 
nutt. are mostly such as would be amenable to P. nig. A patient of mine was 
incidentally cured of a tendency to catch colds by taking P. nutt. for some weeks as a 
prophylactic against measles. Burnett cured with it a case of deafness and oedema of 
left upper eyelid. The proving showed a powerful effect on the menstrual function, 
and Hale reports many cures of retentio mensium:  A young lady, formerly subject 
to retardation of menses, had: Constant chilliness, cold hands and feet, loss of 
appetite, sour eructations, nausea after meals, hemicrania, toothache, melancholy, 
general malaria. Menses two weeks late, took a chill at the time they were due, when 
she had precursory symptoms, no symptoms of menses now. P. nutt. 1 in water 
every two hours. After the first dose the menses came on and the constitutional 
symptoms cleared off.  Plethoric, usually healthy young woman, had menses delay 
two weeks. Continual severe headache, a heaviness and fullness, worse moving or 
stooping, sight dim, complete blindness on stooping or rising suddenly, weight in 
uterine region severe aching extending to back, worse evening. Hands and feet cold, 
weakness in lower limbs. Failed to relieve. P. nutt. Ix, 5 drops every three hours, 
brought speedy improvement. Next day menses came on profusely but without pain, 
two days before the expiration of the eighth week. The Pulsatilla flying pains were 
very noticeable in the proving. Hale reports this case: strong, healthy looking man 
had wandering rheumatic pains chiefly in dorsum of right foot, loins, thighs, chest, 
arms, head. The head pain was a dull, heavy pressure in vertex, nearly constant, with 
occasional sharp pains. Some fever but no local inflammation of joints or muscles. 
Urine scanty, depositing lithates. Acidity of stomach. Appetite good. Bowels 
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normal. P. nutt. Ix cured in three days. Some Peculiar Symptoms are: Home-sick 
feeling. Trembling weakness, weariness, heaviness, Snapping noise in ears. Fidgety 
feet. Colic before and after stool. Colic after eating a pear. Stiffness of fingers. 
Hands hot and dry (a constant symptom). The symptoms are worse coming in from 
open air, after eating, eating a pear, at night, by warmth, by reading, on urinating, on 
walking. better Walking in open air, rubbing with flesh-brush, scratching. 
Chapter – 4  Aim and Objectives 
 
Department of Pharmacology 21            J.K.K. Nattraja College of Pharmacy 
 
 
4.0 AIM AND OBJECTIVES 
 The aim of the study is evaluate the antidiabetic activity of Pulsatilla 
nuttalliana leaves extract 
Diabetes, often referred to by doctors as diabetes mellitus, describes a group 
of metabolic diseases in which the person has high blood glucose (blood sugar), 
either because insulin production is inadequate, or because the body's cells do not 
respond properly to insulin, or both.  
In recent years there has been a tremendous increase in demand for herbal 
drugs due to its safety, efficacy and better therapeutic results Due to its safety, 
efficacy and better therapeutic results. Due to its economic pricing as compared to 
synthetic or allopathic drugs which have several therapeutic complication. 
As we know that everything in this world change time by time since 
thousands of year the ear was of ayurveda or herbal origin drug. But last few 
decades it was replaced by allopathic system of medicine, which was rapidly 
accepted work wide but latter due to its lots of adverse effect and safety profile and 
the people are more believing in natural origin drug. 
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5.0 PLAN OF THE WORK 
 Gathering and authentification of the genuine plant material. 
 Shade drying and granulation of the dried leaves. 
 Sequential extraction of the plant material using petroleum ether, 
ethyl acetate and ethanol. 
 Phytochemical analysis of active extract. 
 Acute toxicity study. 
 In-vitro antidiabetic study using α-amylase inhibition assay. 
 In-vivo antidiabetic study of active extract. 
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6.0 MATERIALS AND METHODS 
6.1 Plant collection and authentification 
The leaves of Pulsatilla nuttalliana were collected from Anthiyur forest area, 
Tamilnadu and which was authenticated.  
6.2 Preparation of coarse powder and Extraction technique 
The leaves were shade dried at room temperature for 10 days. Then these 
were milled into powder by mechanical grinder. This powder was sequentially 
extracted to their increasing polarity with Petroleum ether, Ethyl acetate, Ethanol 
respectively. About 500gm of powdered leaves was uniformly packed into a thimble 
in a soxhlet apparatus and extracted with 1000ml Petroleum ether, Ethyl acetate and 
Ethanol, respectively. Constant heat was provided by Mantox heater for recycling of 
the solvent. The process of extraction continues for 1-2 hours for each solvent. The 
excess solvent was evaporated and the dried extracts were kept in refrigerator at 4ºC 
for their future use in phytochemical analysis and pharmacological screenings. 
6.3 Preliminary phytochemical screening of ethanolic leaves extract of Pulsatilla 
nuttalliana  
  The ethanolic leaves extract of Pulsatilla nuttalliana was used for testing 
preliminary phytochemical screening in order to detect major chemical groups. 
6.3.1 Test for carbohydrates 
 Molisch’s test: Dissolved small quantity of 300mg alcoholic and dried leaves 
extract powder of Pimenta dioica separately in 4ml distilled water and 
filtered. The filtrate was subjected to Molisch’s test.  
 Fehling’s test: Dissolve a small portion of extract in water and treat with 
Fehling’s solution. 
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 Phenols test: The extract was spotted on a filter paper. A drop of 
phosphomolybdic acid reagent was added to the spot and was exposed to 
ammonia vapours. 
6.3.2 Test for flavanoids  
 Shinoda test: To 2 to 3ml of extract, a piece of magnesium ribbon and 1ml of 
concentrated HCl was added. 
 .Lead acetate test: To 5ml of extract 1ml of lead acetate solution was added.  
6.3.3 Test for tannins 
 Braemer’s test: To a 2 to 3ml of extract, 10% alcoholic ferric chloride 
solution was added. 
6.3.4 Test for steroid/terpenoid 
 Liebermann-Burchardt test: To 1ml of extract, 1ml of chloroform, 2 to3ml of 
acetic anhydride and 1 to 2 drops of concentrated Sulphuric acid are added. 
6.3.5 Test for alkaloids 
 Draggendorf’s test: A drop of extract was spotted on a small piece of 
precoated TLC plate and the plate was sprayed with modified Draggendorf’s 
reagent.  
 Hager’s test: The extract was treated with few ml of Hager’s reagen. 
 Wagner’s test: The extract was treated with few ml of Wagner’s reagent. 
6.3.6 Tests for Glycosides 
 Legal’s test: Dissolved the extract [0.1g] in pyridine [2ml], added sodium 
nitroprusside solution [2ml] and made alkaline with Sodium hydroxide 
solution. 
Chapter – 6  Materials and Methods 
 
Department of Pharmacology 25            J.K.K. Nattraja College of Pharmacy 
 
 
6.3.7 Test for Saponins 
 Foam test: 1ml of extract was dilute with 20ml of distilled water and shaken 
with a graduated cylinder for 15 minutes. 
6.3.8 Test for Anthraquinones 
 Borntrager’s test: About 50 mg of powdered extract was heated with 10% 
ferric chloride solution and 1ml of concentrated HCl. The extract was 
cooled, filtered and the filtrate was shaken with diethyl ether. The ether 
extract was further extracted with strong ammonia. 
6.3.9 Test for Amino acids 
 Ninhydrin test: Dissolved a small quantity of the extract in few ml of water 
and added 1ml of ninhydrin reagent. 
6.3.10 Test for fixed oils and fats 
  Press small quantity of the petroleum ether extract between two filter paper. 
Note: the results for the above experiments can be noted as follows. 
 If the response to the test is high it can be noted as +++which indicates that 
the particular group is present as the major class. 
 If the response is average then note it as ++ indicates the presence in 
moderate quantity. 
 If the response is very small then note it as + indicating the presence of only 
in traces. 
 If no response is then negative. 
 
Chapter – 6  Materials and Methods 
 
Department of Pharmacology 26            J.K.K. Nattraja College of Pharmacy 
 
 
6.4 Thin layer chromatographic profiling 
6.4.1 Practical requirements 
 Stationary phases 
 Glass plates 
 Mobile phase 
 Preparation and activation of TLC plates 
 Application of sample  
 Development tank  
 Development technique 
 Detecting or visualizing agents 
6.4.2 Glass plates 
  Specific dimensions like 20 cm*20cm (full plate), 20cm*10cm (half plate), 
20cm*5cm (quarter plate) can be used. It should be good quality and can withstand 
temperature used for drying. 
6.4.3 Preparation and activation of TLC plates   
 Mixture of stationary phase and water forms slurry. TLC plates prepared by 
pouring, dipping, spraying or spreading. In pouring technique, slurry prepared and 
poured on the glass plate. Slurry spread uniformly on glass plate. Plates are dried in 
oven. In dipping technique two plates dipped in slurry, separated and dried. 
Disadvantage is that large quantity slurry required. 
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6.4.4 Spreading technique   
 In this technique TLC spreader is used. The glass plates are stacked on base 
plate. Slurry poured in the reservoir of TLC spreader. Thickness adjusted using knob 
in the spreader. 0.25 mm is normally used thickness for analytical purposes. 
Spreader rolled on the plates and air drying the plates. Plates are activated by 
keeping at 100 degree Celsius to 120 degree Celsius for one hour. Activated plates 
can be stored in thermostatically controlled oven for further use.  
6.4.5 Application of sample 
  The concentration of sample of standard should be minimum for good 
spots. 2- 5ug of 1% solution of standard or sample spotted using capillary tubes. 
Spots should be 2 cm above the base of plate and spotting area should not be 
immersed in mobile phase. At least 4 spots can be spotted on quarter plate.  
6.4.6 Development tank  
The developing tanks require more solvent for developing tank –having 
hump in the middle and require less solvent. It should be lined inside with filter 
paper moistened with mobile phase 
6.4.7 Mobile phase   
The solvent or mobile phase depends on various factors. 
 Nature of substance 
 Nature of stationary phase 
 Mode of chromatography 
 Separation to be achieved. Analytical or preparative 
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6.4.8 Procedure 
Commercial sheet precoated with silica gel are available. Select a solvent by 
testing out the samples in various solvents. Dissolve a small quantity of ethanolic 
extract of Pulsatilla nuttalliana leaves of the unknown in different flask containing 
solvents of different polarity. Place the TLC plates, the spotted side down in to the 
chamber so that the lower the pencil line about the solvents. Remove the plate from 
the development chamber and allowed to dry. Plate is placed under UV light, dark 
spots are observed. 
6.4.9 Quantitative analysis 
   Distance moved by solute                               
                  Rf =       
                              Distance moved by solvent 
                 
Whereas,    Rf = Retardation factor  
6.5 Invitro Antidiabetic Activity of Pulsatilla nuttalliana Leaves Extracts 
6.5.0 Alpha-Amylase Inhibition Assay 
6.5.1 Chemicals or Reagents 
Potato starch, trichloroacetic acid, Folin-Ciocalteau reagents were purchased 
from SD Fine Pvt. Ltd., Mumbai, 3,5-dinitrosalicylic acid, Tris buffer, linoleic acid, 
ammonium molybdate, were purchased from Hi-Media Pvt. Ltd., Mumbai, α-
amylase, α-glucosidase enzymes, xanthine oxidase, quercetin, hypoxanthine, 
pyrocatechol were purchased from SRL Pvt. Ltd., Mumbai. Glucose assay kit from 
Agappe diagnostic Pvt. Ltd., Kerala, Acarbose was obtained from Bicon Pvt. Ltd., 
Chennai, ferrozine, (2'2-azobis (2-amidino propane) dihydrochloride), butylated 
hydroxy toluene from Loba Cheme. All other chemicals used in the study were 
obtained commercially and were of analytical grade. 
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6.5.2 Instrument used 
UV-visible Spectrometer (Systronic double beam- UV-2201). 
6.5.3 Preparation of extract 
Leaves extraction used in invitro and invivo studies were prepared by using 
suitable solvents (Carboxy methyl cellulose). 
6.5.4 Experimental procedure for α-amylase inhibition assay 
A total of 500 µl of test samples and standard drug (100-1000µg/ml)  
were added  to  500  µl  of  0.20  mM  phosphate  buffer  (pH  6.9)  containing  
α-amylase (0.5mg/ml) solution and were incubated at 25°C for 10 min. After 
these, 500 µl of a 1% starch solution in 0.02 M sodium phosphate buffer 
(pH 6.9) was added to each tube. The reaction mixtures were then incubated 
at 25°C for 10 min. The reaction was stopped with 1.0 ml of 3, 5 dinitro 
salicylic acid colour reagent. The test tubes were then incubated in a boiling 
water bath for 5 min, cooled to room temperature. The reaction mixture was 
then diluted after adding 10 ml distilled water and absorbance was measured 
at 540 nm.  Control represent 100% enzyme activity and were conducted in 
similar way by replacing extract with vehicle. 
Calculation of 50% Inhibitory Concentration (IC50) 
The concentration of the plant extracts required to scavenge 50% of the 
radicals (IC50) was calculated by using the percentage scavenging activities at 
five different concentrations of the extract. Percentage inhibition (I %) was 
calculated by 
   (Ac-As) 
I % =      --------------- x 100 
  Ac 
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whereas, 
Ac      = Absorbance of the control 
As      = Absorbance of the sample. 
6.6 Acute Oral Toxicity Study 
 In a research study when a drug is administered to a biological system there 
will be some interactions may happen .In most case these are desired and useful, but 
many effects are not advantageous. Acute, subacute and chronic toxicity studies are 
performed by the manufacturers in the investigation of a new drug. Acute toxicity is 
involved in estimation of LD50 (It is the lethal dose (cuasing death)to 50% of tested 
group animals)54. 
6.6.1 LD50 (Median Lethal Oral Dose) 
LD 50 (median lethal oral dose) is a statistically derived oral dose of a 
substance that can be expected to cause death in percent of animals when 
administered by the oral route. The LD50 value is expressed in terms of weight of 
test substance per unit weight of animal (mg/kg) 
  In this study acute toxicity study was carried out in wistar albino rats. The 
procedure was followed by using OECD 423(Acute toxic class method).The rats are 
fasted overnight, prior to dosing. The three dose levels are administered by the help 
of oral feeding needle over the prior of 24 hours .After the drugs has been 
administered, food may be withheld for a further 3-4 hours in rats. The purpose of 
sighting study is to allow selection of the appropriate starting dose for main study. 
The test substance is administered to a single animal in a sequential manner 
following from the fixed dose levels of 5, 50, 300 and 2000mg/kg. The interval 
between dosing of each level is determined by the mortality/onset, duration and 
severity of toxic signs over the period of 24 hours, special attention given during the 
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first 4 hours. Four hours after the drug administration, provide the food and water 
for 14 days and daily observed some parameters such as food intake, water intake, 
mortality, onset, Duration and severity of toxic signs. The animal weight is recorded 
on weekly once. On the day fourteen all the animals are sacrificed, to isolate the 
organs and observe the histopathological changes. Based on the mortality result of 
sighting is decided and carried out with five animals per dose level (5 or 50 or 300 
or 2000mg/kg).Based on the mortality result on 14th day of observation, the doses 
for invivo study are selected.  
6.7 In-vivo Antidiabetic Activity of Pulsatilla Nuttalliana Leaves Extract in 
Streptozotocin Induced Diabetic in Wistar Rats. 
Wistar rats (150- 200 grams) of both sexes were used in the study and 
were obtained from the Animal house, Jkkncp, Kumarapalayam. The studies 
were performed with the approved by the institutional animal ethical 
committee, and these animals were used to evaluate Antidiabetic activity of 
pulsatilla nuttalliana leaves extract. Prior to the experiment the rats were 
housed in a clean polypropylene cages (6 rats/ cages) for a period of 7 days 
under standard temperature (25 - 30o c), relative humidity (45 – 55%), dark / 
light cycle (12 /12 hrs)..  The animals were put in overnight fasting were 
deprived of food for 16 hrs but allowed free access of water. 
6.7.1 Chemicals: 
Streptozotocin from Loba Chemie. Standard Glibenclamide (Daonil) from 
Aventis Pharma. Ethanol (Analytical grade) and 5% Dextrose solution Glucose 
Estimation Kit from Gluco Dr Super sensor 
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6.8 Hypoglycemic Test 
Groupings were done as follows:  
 Group I served as control – Carboxy Methyl Cellulose (CMC) 1% 
(0.3ml\100g rat),  
 Group II served as negative control – Streptozotocin (100 mg/kg, I.P) 
 Group III served as Positive control – Glibenclamide (2mg /kg), 
 Group IV served as aqueous ethanolic extract of Pulsatilla nuttalliana – 
(400mg/kg).  
Blood samples were collected by the tail nipping method and glucose level 
checked by glucometer.  After drug Administration blood samples have been 
collected different time intervals at 30, 60 and 120. 
6.9 Oral Glucose Tolerance Test 
Groupings were done as follows:  
 Group I served as control – Carboxy Methyl Cellulose (CMC) 1% 
(0.3ml\100g rat),  
 Group II served as Positive control – Glibenclamide (2 mg /kg),  
 Group III served as aqueous ethanolic extract of Pulsatilla nuttalliana – 
(400mg/kg). 
 All the groups of animals were fasted for 24h and blood samples were collected 
before drug or solvent treatment. The drug, extract and solvent, have been 
administered to different groups and 30mins later all the groups of rats were treated 
with glucose orally at dose 10gm/kg body weight by using oral feeding needle.  
Blood samples were collected by the tail vein method and glucose level checked by 
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glucometer.  After drug Administration blood samples have been collected different 
time intervals at 30, 60 and 120. 
6.10 Induction of diabetes to animals 
The single dose (100 mg/kg b.w., i.p.) of streptozotocin monohydrate 
dissolved in sodium citrate buffer was used for the induction of diabetes in rats 
after overnight fasting. After 1 hr of streptozotocin monohydrate administration, 
the animals were given feed and libitum and 5% dextrose solution was  also  given  
in  feeding  bottle  for  a  day  to overcome early hypoglycaemic  phase. The 
animals were stabilized for a week and animals showing blood glucose level 
more than 200 mg/dl were selected for the study. 
6.11 Experimental design 
Four groups of rats six in each  groups  received the  following  treatment 
schedule for 14 days. 
Group I        -    Normal control (normal saline 10 ml /kg, P.O) 
        Group II      -    Streptozotocin treated control (100 mg/kg, I.P)  
        Group III     -    Streptozotocin (100 mg/kg, I.P) + 
 Standard drug Glibenclamide (2 mg/kg, P.O). 
Group IV      -  Streptozotocin (100 mg/kg, i.p.) + EEPN. (400 mg/kg, P.O) 
 Plant leaves extract, standard drug and normal saline were administered with 
the help of oral feeding needle. Group I serve as normal control which received 
normal saline for 14 days. Group II to Group I V were diabetic control rats. 
Group IV (which previously received streptozotocin 100mg/kg) were given fixed 
doses  of ethanol leaves extract (400 mg/kg, P.O) of Pulsatilla nuttalliana leaves 
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extract and group III received standard drug Glibenclamide (2 mg/kg,P.O) for 14 
consecutive days.(EEPN-Ethanolic extract of Pulsatilla nuttalliana ). 
6.11.1 Collection of blood samples 
Fasting blood samples were drawn from tail vein of rats at weekly intervals 
till the end of the study 1, 7, and 14 days. 
6.11.2 Estimation of biochemical parameters Serum blood glucose 
On 1, 7, and 14 days fasting  blood samples were collected and analyzed the 
blood glucose. 
6.11.3 Blood glucose level 
The blood glucose level test measures the amount of glucose in the blood 
sample obtained from the animals. The test is usually performed to check for 
elevated blood glucose levels which can be an indication of diabetes or insulin 
inhibition. 
6.11.4 Statistical analysis 
Statistical analysis was done by using GRAPHPAD PRISM 5.0.All the 
values of Biochemical parameters and body weight were expressed as Mean ± 
Standard Error Mean (SEM). The values were analyzed for statistical 
significance using one- way analysis of variance (ANOVA), comparison was 
done by using Dunnett’s t test. P values < 0.05 were considered as significant, P 
values < 0.01 were considered as very significant, P values < 0.001 were 
considered as highly significant and P>0.05 were considered as not significant.  
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7.1 RESULTS  
7.1.1 Phytochemical studies 
 Table No. 2: Results of ethanolic extract of Pulsatilla nuttalliana  
Class of compounds Tests performed Results  
Carbohydrates Molisch’s test 
Fehling’s test 
- 
- 
Phenols Phosphomolybdic acid test +++ 
Flavonoids Shinoda test 
Lead acetate test 
++ 
++ 
Tannins Braemer’s test _ 
Alkaloids Wagner’s 
Mayer’s 
Draggendrof’s test 
+ 
+ 
+ 
Glycosides Legal’s test 
Brontranger’s test 
+ 
+ 
Saponins Foam test + 
Sterols Salkowski’s test _ 
Amino acids Ninhydrin test _ 
Terpenoids Lieberman Burchardt test + 
 
+ In traces 
++ Present in moderate amount 
+++ More amounts is present 
-Absence 
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The phytochemical studies results revealed that the Molisch’s test no 
characteristic observation indicated the absence of carbohydrates, by 
phosphomolybdic acid test Blue coloration of the spot indicated the presence of 
phenols. Shinoda test and Lead acetate test gave pink or red coloration of the 
solution indicated the presence of flavonoids Flocculent white precipitate also 
indicated the same. There is no dark blue or greenish grey coloration of the solution 
indicated the absence of tannins in the drug. No characteristic observation for 
steroids and dark pink or red coloration of the solution indicated the presence of 
terpenoids. Orange coloration of the spot indicated the presence of alkaloids. Yellow 
or reddish brown precipitation precipitation indicated the presence of alkaloids. Pink 
to red colour solution indicates the presence of glycosides. No layer of foam 
formation indicates the absence of Saponins. If the response to the test is indicated 
table-1high it can be noted as++++ or +++ which indicates that the particular group 
is present as the major class. If the response is average then note it as ++ indicates 
the presence in moderate quantity and note it as + indicating the presence of only in 
traces. If no response is then negative.   
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7.1.2 TLC study  
           Table No: 3, Results of ethanolic extract of Pulsatilla nuttalliana  
S.No. Solvents Concentration Rf  value 
1. Toluene + Ethyl acetate 7:3 0.61 
2. 
Toluene + Ethyl acetate + Glacial 
acetic acid 
5:5:1 0.75 
3. Petrolium ether+Chloroform 7:3 0.55 
4. Ethyl acetate + Methanol 1:1 0.89 
5. Hexane+Dichloro methane 1:1 0.68 
6. Ethyl acetate + Methanol 3:1 0.60 
7. Dichloro methane +Hexane 3:1 0.73 
 
Rf Value range high-Polar substances present. 
Rf value range low-Low polar substance present. 
Solubility of compounds depend upon the polarity of solvents. 
Obtained Rf values were confirmed by standard Rf values. 
 Rf values obtained for my extract ranges from 0.56 to 0.88,So my extract may 
contain compounds like Flavanoids, Glycosides and Alkaloids. 
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7.1.3 Appearance and percentage yield of EEPN (Ethanolic Extract of Pulsatilla 
nuttalliana leaves) 
EEPN was a semisolid brownish colour extract and the percentage yield was 
found to be 14.35% 
7.1.4 In-vitro Antidiabetic Study     
             Table No:4, α-Amylase Inhibition of Petroleum Ether extract of   
Pulsatilla nuttalliana leaves 
    Concentration(µg/ml)                          IC50 % 
0 0 
25 29 
50 33 
75 42 
100 53 
125 56 
 
Figure No. 4: α amylase inhibition of petroleum Ether extract of Pulsatilla 
nuttalliana 
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Table No.5: α-Amylase Inhibition of Ethyl acetate Extract of Pulsatilla 
nuttalliana leaves 
Concentration(µg/ml)                          IC50 % 
0 0 
25 33 
50 42 
75 49 
100 57 
125 61 
 
Figure No.5: α amylase inhibition of Ethyl acetate extract of Pulsatilla nuttalliana 
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Table No.6:, α-Amylase Inhibition of  Ethanolic Extract of Pulsatilla 
nuttalliana leaves 
Concentration(µg/ml)                 IC50 % 
0 0 
25 30 
50 35 
75 51 
100 55 
125 62 
 
Figure No.6: α amylase inhibition of Ethanolic Extract of Pulsatilla nuttalliana 
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Table No: 7, α-Amylase Inhibition of Acarbose  (Positive control) 
 
 
 
 
 
 
 
Figure No: 7 α-Amylase Inhibition of Acarbose 
 
Concentration(µg/ml)                         IC50 % 
0 0 
25 25 
50 45 
75 53 
100 56 
125 65 
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7.1.4 Result 
 IC50 % of Petrolium ether extract of Pulsatilla nuttalliana leaves = 91 
µg/ml 
  IC50 % of Ethyl acetate extract of Pulsatilla nuttalliana leaves     =  81 
µg/ml        
  IC50 % of Ethanolic extract of Pulsatilla nuttalliana leaves          =  74 
µg/ml           
  IC50 % of Acarbose (Positive control)  =  62 µg/ml      
Minimum IC50 % was found in Ethanolic extract of Pulsatilla nuttalliana leaves 
which resemblance to IC50 % of positive control, So Ethanolic extract of 
Pulsatilla nuttalliana contain active constituents of antidiabetic. 
Table No: 8, Hypoglycemic Test 
Treatment 
Dose 
mg/kg 
Blood Glucose Level (mg/dl) 
0 min 0.5hr 1 hr 
Control 
Carboxymethyl 
Cellulose 
1% 67.22±0.15 69.05±0.46 70.93±1.87 
Positive Control 
Glibenclamide 
2 68.93±0.54 53.75±1.06** 33.04±1.22*** 
Aqueous 
Ethanolic Extract 
Of Pulsatilla 
Nuttalliana  
400 68.64±0.74 54.65±0.42** 35.66±0.58*** 
Chapter – 7  Results & Discussion 
 
Department of Pharmacology 43            J.K.K. Nattraja College of Pharmacy 
 
 
The glucose levels were analyzed by using glucometer and each value is the 
mean ± standard error (n= each group consist of 6 animals) (p<0.05)*, 
(p<0.001)**& (p<0.0001)*** as compared to control & positive control group 
evaluated by one  way, ANOVA followed by Dunnet ‘t’ test. 
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Figure No:  8 - Hypoglycemic Test – 30 Minutes 
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Figure No: 9 - Hypoglycemic Test – 1st hourly 
1 H O U R L Y
c
o
n
tr
o
l
p
o
s
it
iv
e
 c
o
n
tr
o
l
E
x
tr
a
c
t  
4
0
0
m
g
/k
g
0
2 0
4 0
6 0
8 0
G R O U P S
B
L
O
O
D
 
G
L
U
C
O
SE
 
L
E
V
E
L
 
(m
g/
dl
)
 
Chapter – 7  Results & Discussion 
 
Department of Pharmacology 45            J.K.K. Nattraja College of Pharmacy 
 
 
The hypoglycemic test results have shown Table No:8, which indicated  aqueous 
ethanolic extract of Pulsatilla nuttalliana treated animals 400 mg/kg ,  significantly 
decreased in blood glucose level (18.83±3.879↓) (P<0.05)*, (P<0.001)**&  
(P<0.0001)*** when compared to control and positive control. 
g) In-vivo antidiabetic study 
Table No: 9, Results of the effects of ethanolic extract on blood Glucose levels 
S. 
No. 
 
Treatment 
 
Blood glucose level (mg/dl) day 
 Day 1 Day 7 Day 14 
1 Normal control 
10 ml/kg P.O 
80.16±1.44 75.7±4.014 77.23± 0.98 
2 Negative control 
100 mg/kg I.P 
266.19±0.46 270.1±2.9 276.32±0.51 
3 Positive control 
(Glibenclamide 
2mg/kg) P.O 
256.49±0.86 135.63±3.8*** 111.92±0.93*** 
4 EEPN 400 mg/kg 
P.O 
262. 92±1.06 174.04±0.62
*** 
163.56±0.58** 
 
EEPN-Ethanoloc extract of Pulsatilla nuttalliana leaves 
(The values were expressed as Mean ± S.E.M. (n=6 animals in each group). 
The experimental results have indicated on Table No:9. The negative control 
group glucose levels were significantly increased when compared to each other 
groups. All the groups of animals were affected in diabetes, which indicated blood 
glucose levels were slight changes in the blood glucose level (4.13±1.207↓& 
1.±0.93↑) for normal control group at 7th and 14th days. On day 7th glucose levels 
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were significantly decreased glibenclamide 2mg/kg treated group (121.2±1.414↓& 
23±1↓) (P<0.05)*, (P<0.001) **& (P<0.0001) *** when compared with control 
group at 7th and 14th days. The ethanolic leaves extract of Pulsatilla nuttalliana 
treated group 400 mg/kg were dose dependent manner decreased (P<0.0001)*** 
(90±1.67↓) when compared  with control group but positive control have more anti 
diabetic activity  at 7th day.  The aqueous ethanolic leaves extract of Pulsatilla 
nuttalliana at the dose level 400mg/kg have equipotent activity (120.2±1.414↓)when 
compared with positive control at 7th day. The ethanolic leaves extract of Pulsatilla 
nuttalliana 400 mg/kg have been expressed dose dependent anti diabetic action 
(P<0.0001) *** when compared to control and positive control. On day 14th, 
ethanolic leaves extract of Pulsatilla nuttalliana treated animals 400 mg/kg 
significantly decreased and maintain the blood glucose level (5. 11±1.08↓), 
(P<0.0001) *** when compared to control and positive control.  
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Table No:10  Oral Glucose Tolerance Test  
Treatment 
Dose 
mg/kg 
BLOOD GLUCOSE LEVEL (mg/dl) 
0 min 0.5hr 1 hr 1.5hr 2 hr 2.5hr 3hr 
Control 
Carboxymet
hyl 
Cellulose(C
mc) 
1 % 69.12±0.56 141.91±0.23 188.11±0.32 173.21±0.32 158.03±0.62 154.20±0.76 131.21±0.03 
Positive 
Control 
Gliben 
clamide 
2 68.90±0.45 105.31±0.64** 111.54±0.43*** 94.01±0.43*** 82.41±0.71*** 78.23±0.71*** 75.62±0.21*** 
Aqueous 
Methanolic 
Extract of 
Pulsatilla 
Nuttalliana  
400 68.53±0.13 116.23±1.32** 120.21±0.12** 104.11±0.04*** 94.11±0.41***  87.21±0.31*** 84.30±1.92*** 
 
The glucose levels were analyzed by using glucometer and all values are expressed as Mean±SEM (n=6), Group 2 was compared with 
group 1, Groups —3,4 were compared with group 2; *p<0.05, **p<0.01,***p<0.001 evaluated by one way, ANOVA followed by 
Dunnet ‘t’ test. 
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Figure No: 10 - Oral Glucose Tolerance Test- Initial Zero minutes 
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Figure No:11 - Oral Glucose Tolerance Test- 30 minutes 
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Figure No:12 - Oral Glucose Tolerance Test- At 1st hourly 
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Figure No:13 - Oral Glucose Tolerance Test- At 1.5 hourly 
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Figure No:14 - Oral Glucose Tolerance Test- At 2nd hourly 
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Figure No:15 - Oral Glucose Tolerance Test- At 2.5 hourly 
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Figure No:16 - Oral Glucose Tolerance Test- At 3rd hourly 
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The Oral Glucose Tolerance Test (OGTT) results have been expressed on 
Table Half hour after the glucose treatment, all the groups of animal blood glucose 
levels were significantly increased (74.5±3.863↑, 35.2±6.6905↑, 59.5±3.764↑ & 
65.58±3.762↑). The blood glucose levels were significantly decreased for ,  aqueous 
ethanolic extract of Pulsatilla nuttalliana 400 mg/kg (65.58±3.762↓ ) ↓), (P<0.0001) 
** when compared to control and positive control at 1hour and each and every ½ 
hour blood glucose levels( 400 mg/kg:17.9±1.422,9.97±0,14.7±1.093&5±0.696) 
(P<0.05)*, (P<0.001)**&  (P<0.0001)*** the extract treated group of animals 
compared to control and positive control, the EEPN  400mg/kg produce the 
equipotent activity. 
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7.2 DISCUSSION 
The α-amylase, enzyme that plays a role in digestion of starch and glycogen 
are considered  a  strategy  for  the  treatment  of  disorders  in  carbohydrate 
uptake,  such  as diabetes.  Pancreatic α-amylase   is a key enzyme in the 
digestive system and catalyses the initial step in hydrolysis of starch to a 
mixture of smaller. Sequential extraction was done according to increasing 
polarity order (Petrolium ether,Ethyl acetate and Ethanol). Each extracts were 
tested for α-amylase inhibition to get the extraction with minimum IC50 value.  As 
per the above mechanism all the extract have concentration dependent affinity 
towards the inhibition of α-amylase. Finally ethanolic extract was observed as more 
active extract.. In  this  present  study  Acute  toxicity  study  was    carried  out  in  
rats.  The procedure was followed by using OECD 423 (Acute Toxic Class 
Method). The acute toxic class method is a step wise procedure with three animals 
of a single sex per step. Average  two to three steps  may  be necessary.  The 
method used to defined doses (2000, 1000, 500, 50, 5 mg/kg body weight, Up-
and-Down Procedure). The starting dose level of EEPN was 2000 mg/kg body 
weight p.o as most of the crude extracts posses LD50 value more than 2000 mg/kg 
p.o and also found to be the maximum safe dose. Observe for signs for toxicity and 
were noted for 14 days. The onset of toxicity and signs of toxicity also noted. 
Hence 1/5th (400mg/kg) of this dose were selected for further study. The principle 
involved in the alloxan induced diabetes mellitus in rats, STZ,  a beta cytotoxic, 
diabetes induced chemical but wide variety of animal  species  by damaging  the 
insulin  secreting  cells  of the pancreas.  Literature sources indicate that the STZ 
induced rats  are  hyperglycaemic.  The treatment of lower doses of STZ (100mg/kg  
b.w.)  produced  partial  destruction  of pancreatic  β-cells  even though the 
animals become permanently diabetic. Thus these animals have surviving β-cells 
and regeneration is possible. It is well known that the sulfonylurea’s act by 
directly stimulating the β-cells of the islets of Langerhans to release more insulin 
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and these compounds are active in mild alloxan induced diabetes. Invivo anti 
diabetic screening was performed for the confirmation of above mechanism of 
action was undergone the ethanolic extract of Pulsatilla nuttalliana in biological 
system (Which was already resulted for α-amylase inhibitory activity by Invitro 
methods). At the end of the ethanolic extract of Pulsatilla nuttalliana.(400  
mg/kg  p.o.) showed statistically significant  decrease  in  blood  glucose levels. 
So the ethanolic extract of Pulsatilla nuttalliana showed antidiabetic activity. This 
work will be useful for further diabetes mellitus and it’s related diseases research 
worker to develop new entity for the treatment of diabetes mellitus. 
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8.0 SUMMARY AND CONCLUSION 
The leaves extraction has been performed by sequential extraction method 
The leaves of Pulsatilla nuttalliana using the solvent with increasing polarity order 
(petroleum ether, ethyl acetate and ethanol) and the active extract was tested by 
invitro antidiabetic screening method. The invitro antidiabetic study have been 
performed based on the α-amylase inhibition assay. Each extracts were tested for α-
amylase inhibition and the extract with minimum IC50 have been undergone phyto 
chemical screening. The preliminary phytochemical tests was performed to identify 
the active phytochemicals present in the ethanolic extract of Pulsatilla nuttalliana 
and showed the presence of Phenols, Flavanoids, Alkaloids, Glycosides, Saponins 
and Terpenoids. The in-vivo antidiabetic activity of Ethanolic extract of Pulsatilla 
nuttalliana leaf was tested by using STZ induced diabetic rat. Acute toxicity study 
was carried out in rats. The procedure was followed by OECD 423 (Acute toxicity 
class method). 1/5th (400mg/kg) of the maximum safe dose (2000mg/kg) were 
selected for further study. Fasting blood sample were drawn from tail vein of rats at 
weekly intervals till the end of the study 1,7 and 14 days. On these days fasting 
blood glucose were collected and analysed for glucose. At the end of the study (14th 
day)the ethanolic extract of Pulsatilla nuttalliana leaf (400 mg/kg p.o) treated 
diabetic groups showed statistically significant decrease in blood glucose similar to 
the standard drug glibenclamide (2mg/kg), which indicated block the alfa amyalase 
activity. The present study suggested that the isolation of active constituents from 
ethanolic extract of Pulsatilla nuttalliana leaf and characterize the compounds by 
using preliminary phytochemical studies. 
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